Skip to main content

Table 1 Baseline clinical characteristics of patients with and without adverse event

From: The relation between atherogenic index of plasma and cardiovascular outcomes in prediabetic individuals with unstable angina pectoris

 

Total population (n = 1096)

Without event (n = 955)

With event (n = 141)

P value

Age, years

59.47 ± 9.86

59.77 ± 9.89

57.40 ± 9.45

0.008

Sex, male, n (%)

766 (69.9)

659 (69.0)

107 (75.9)

0.118

BMI, kg/m2

25.90 ± 3.44

25.79 ± 3.44

26.67 ± 3.38

0.004

SBP, mmHg

130.17 ± 17.17

130.34 ± 17.35

129.05 ± 15.92

0.407

DBP, mmHg

77.43 ± 10.84

77.37 ± 10.96

77.86 ± 10.03

0.615

Smoking, n (%)

528 (48.2)

458 (48)

70 (49.6)

0.776

Medical history, n (%)

    

Hypertension

664 (60.6)

588 (51.6)

76 (53.9)

0.099

Dyslipidemia

784 (71.5)

690 (72.3)

94 (66.7)

0.203

Prior PCI

295 (26.9)

251 (26.3)

44 (31.2)

0.259

Laboratory results

    

TG, mmol/L

1.53 ± 1.12

1.44 ± 0.97

2.12 ± 1.73

< 0.001

TC, mmol/L

4.11 ± 1.04

4.09 ± 1.02

4.20 ± 1.21

0.227

LDL-C, mmol/L

2.41 ± 0.89

2.40 ± 0.87

2.48 ± 1.00

0.353

HDL-C, mmol/L

1.17 ± 0.27

1.18 ± 0.28

1.06 ± 0.23

< 0.001

AIP

0.06 ± 0.28

0.04 ± 0.27

0.25 ± 0.26

< 0.001

CRP, mg/L

2.41 ± 4.33

2.38 ± 4.27

2.60 ± 4.73

0.581

Cr, mg/dL

71.25 ± 14.98

71.16 ± 15.05

71.90 ± 14.50

0.583

eGFR, mL/(min * 1.73 m2

95.43 ± 12.79

95.24 ± 12.76

96.71 ± 13.00

0.203

SUA, µmol/L

350.84 ± 86.07

348.71 ± 85.47

365.23 ± 88.99

0.033

FBG, mmol/L

5.93 ± 1.37

5.92 ± 1.37

5.97 ± 1.37

0.680

HbA1c, %

5.99 ± 0.22

5.99 ± 0.22

5.96 ± 0.21

0.067

Pre-admission medication, n (%)

    

Antiplatelet therapy

1094 (99.8)

953 (99.8)

141 (100.0)

1

Statins

1091 (99.5)

950 (99.5)

141 (100.0)

0.848

ACEI

148 (13.5)

125 (13.1)

23 (16.3)

0.361

ARB

802 (73.2)

688 (72.0)

114 (80.9)

0.036

nitrate medication

1011 (92.2)

883 (92.5)

128 (90.8)

0.598

β-blocker

878 (80.1)

759 (79.5)

119 (84.4)

0.210

Angiographic data

Total population (n = 427)

Without event (n = 366)

With event (n = 61)

 

Target vessel territory, n (%)

    

LM

33 (7.7)

31 (8.5)

2 (3.3)

0.251

LAD

338 (79.2)

291 (79.5)

47 (77.0)

0.789

LCX

230 (53.9)

199 (54.5)

31 (50.8)

0.707

RCA

254 (59.5)

212 (57.9)

42 (68.9)

0.142

SYNTAX score

12.74 ± 7.55

12.92 ± 7.61

11.66 ± 7.19

0.229

  1. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; PCI: percutaneous coronary intervention; TG: triglyceride; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; AIP: atherogenic index of plasma; CRP: C-reactive protein; Cr: creatinine; eGFR: estimated glomerular filtration rate; SUA: serum uric acid; FBG: fasting blood-glucose; HbA1c: glycosylated hemoglobin A1c; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; LM: left main artery; LAD: left anterior descending artery; LCX: left circumflex artery; RCA: right coronary artery; SYNTAX: synergy between PCI with taxus and cardiac surgery
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us